ClinicalTrials.Veeva

Menu

Observational Study for the Evaluation of the Clinical Performance and Safety Profile of the GALAXY FIXATION™ System and Orthofix Implantable Devices: GALAXY Study

O

Orthofix

Status

Active, not recruiting

Conditions

Vertically Stable Pelvic Fractures
Fractures of the Long Bones
Vertically Unstable Pelvic Fractures

Treatments

Device: Galaxy Fixation System and Orthofix implantable devices

Study type

Observational

Funder types

Industry

Identifiers

NCT06690437
OCI_2204

Details and patient eligibility

About

The GALAXY FIXATIONTM System and Orthofix implantable devices study intends to evaluate the clinical performance and safety profile of the study medical/investigational devices in the standard clinical practice. The study will be conducted in three sites located in Italy considered reference sites for the treatment of adults and paediatric patients with fractures of the long bones, vertically stable pelvic fractures, or vertically unstable pelvic fractures as a treatment adjunct, where the usage of GALAXY FIXATION™ System and Orthofix implantable devices were part of the normal clinical practice. The participant investigators will retrospectively include a maximum of 118 patients in which GALAXY FIXATIONTM System and Orthofix implantable devices were used. No diagnostic or therapeutic intervention outside routine clinical practice will be applied.

Enrollment

118 estimated patients

Sex

All

Ages

29+ days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The patient directly or indirectly (through a respondent) expressed his willingness to participate in the Study by signing and dating informed consent.

  2. Patient who had a regular indication for the following surgical intervention with the GALAXY FIXATION™ System and Orthofix implantable devices according to manufacturer's IFUs:

    • fractures of the long bones or;
    • Vertically stable pelvic fractures or vertically unstable pelvic fractures as a treatment adjunct.
  3. Patients equal or older than 29 days.

  4. Patients who had a regular indication for external fixation according to the investigator criteria.

  5. Patients with clinical data registered in her/his medical records sufficient to assess the safety and efficacy endpoints of the study

Exclusion criteria

  1. The patient is participating in other clinical studies or did he/she participate in the 3 months before signing the informed consent in other clinical studies.
  2. The patient needed the application of or had already in-situ concomitant devices that couldn't be safely removed (except for permitted concomitant devices).
  3. The patient was treated with more than one GALAXY FIXATION™ System or non Orthofix implantable devices.
  4. Patient who had mental or physiological conditions who are unwilling or incapable of following postoperative care instructions.
  5. Patient who had previous infections in the fracture area.
  6. Patients who had malignancy in the fracture area.
  7. Patients who had neuromuscular deficit or any other conditions that could influence the healing process.
  8. Patients who had suspected or documented metal sensitivity reactions as it could result in a treatment failure in the intended population

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems